The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity
Abstract
Summary: The observation that the glycolipid α‐galactosylceramide (α‐GalCer) is a potent stimulator of natural killer T (NKT) cells has provided an important means for investigating NKT cell biology. α‐GalCer is presented on CD1d to the invariant NKT receptor, leading to interleukin‐12 (IL‐12) production by dendritic cells (DCs) and to NK cell activation. We review our research on the tumor‐protective properties of α‐GalCer, particularly the major role played by DCs. We compared administration of α‐GalCer on mature DCs with soluble glycolipid and found that DCs induced more prolonged interferon‐γ (IFN‐γ) production by NKT cells and better protection against B16 melanoma. Human α‐GalCer‐loaded DCs also expanded NKT cell numbers in cancer patients. α‐GalCer‐activated NKT cells were then found to induce DC maturation in vivo. The maturing DCs produced IL‐12, upregulated co‐stimulatory molecules, and induced adaptive immunity to captured cellular antigens, including prolonged, combined CD4+/CD8+ T‐cell immunity to dying tumor cells. Surprisingly, co‐stimulator‐poor tumor cells, if directly loaded with α‐GalCer (‘tumor/Gal’) and injected intravenously, also induced strong NKT‐ and NK‐cell responses. The latter killed the tumor/Gal, which were subsequently cross presented by CD1d on DCs to elicit DC maturation and prolonged adaptive T‐cell immunity, which lasted 6–12 months. These findings help explain tumor protection via α‐GalCer and urge development of the DC‐NKT axis to provide innate and adaptive immunity to human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Cited by
Cross-priming in health and disease
Kurts, C., Robinson, B. W. S., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2780 · Cited by 429
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems
Boyaka, P. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601775 · Cited by 257
Pinchuk, L. M., & Filipov, N. M. (2008) · Immunity & Ageing · doi:10.1186/1742-4933-5-1 · Cited by 108
Arrenberg, P., Halder, R., & Kumar, V. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21597 · Cited by 81
Metadata
- Authors
- Fujii, S., Shimizu, K., Hemmi, H., & Steinman, R. M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2007-10-30
- Volume
- 220
- Issue
- 1
- Pages
- 183-198
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2089324317
- Cited by
- 162
- References
- 1
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity. https://app.cochat.ai/papers/10.1111/j.1600-065x.2007.00561.x
- The paper
- Fujii, S., Shimizu, K., Hemmi, H., & Steinman, R. M. (2007). Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.2007.00561.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.